Lexicon Pharmaceuticals Inc. is Today's Focus Stock on MicroStockProfit.com
January 07 2011 - 6:50AM
MicroStockProfit.com announces an investment report featuring
Lexicon Pharmaceuticals Inc. (Nasdaq:LXRX). The report includes
financial, comparative and investment analyses, and industry
information you need to know to make an educated investment
decision.
The full report is available at:
www.microstockprofit.com/lp/LXRX
Lexicon Pharmaceuticals Inc. (LXRX) is a biopharmaceutical
company focused on discovering breakthrough treatments for human
disease. It has currently four drug candidates in mid-stage
development for diabetes, irritable bowel syndrome, carcinoid
syndrome and rheumatoid arthritis. LXRX has used its proprietary
gene knockout technology to identify more than 100 promising drug
targets. The Company has focused drug discovery efforts on these
biologically-validated targets to create its extensive pipeline of
clinical and preclinical programs.
For only $19 a month, you can sign up for our real-time stock
alert service. Click here to join now:
http://www.pennystocklive.com/premium-membership/
In the report, the analyst notes:
"Shares of LXRX jumped Thursday after the Company reported its
key drug for type-2 diabetes, LX4211, had shown encouraging data in
a mid-stage study. The Company said a new tablet formulation of
LX4211 worked as well as or better than a liquid formulation used
in previous clinical trials. The drug's liquid version had already
shown promising results in a mid-stage study last year.
"The recent study showed that the oral version of the said drug
significantly increased the presence of GLP-1, an important peptide
that mediates insulin and glucagon secretion."
To read the entire report visit:
www.microstockprofit.com/lp/LXRX
See what investors are saying about LXRX at
http://www.stockhideout.com
Get breaking news on LXRX at http://thestockmarketwatch.com/
MicroStockProfit.com is a small-cap research and investment
commentary provider. MicroStockProfit.com strives to provide a
balanced view of many promising small-cap companies that would
otherwise fall under the radar of the typical Wall Street investor.
We provide investors with an excellent first step in their research
and due diligence by providing daily trading ideas, and
consolidating the public information available on them. For more
information on MicroStockProfit please visit:
http://www.microstockprofit.com
MicroStockProfit.com Disclosure
MicroStockProfit.com is not a registered investment advisor and
nothing contained in any materials should be construed as a
recommendation to buy or sell any securities. MicroStockProfit.com
is a Web site wholly owned by BlueWave Advisors, LLC. Neither
MicroStockProfit.com nor its affiliates have a beneficial interest
in the mentioned company; nor have they received compensation of
any kind for any of the companies listed in this communication.
Please read our report and visit our Web site,
MicroStockProfit.com, for complete risks and disclosures.
CONTACT: Brian Johnson
info@microstockprofit.com
1-888-307-2850
Lexicon Pharmaceuticals (NASDAQ:LXRX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Lexicon Pharmaceuticals (NASDAQ:LXRX)
Historical Stock Chart
From Jul 2023 to Jul 2024